543 filings
Page 2 of 28
8-K
sfvus2ld9taiqzxxrko5
28 Sep 23
Palatin Reports Fourth Quarter and Fiscal Year Ended 2023 Financial
8:02am
8-K
mwipicfkzk 7t
8 Sep 23
Palatin to Present at the H.C. Wainwright
8:00am
8-K
bcirkx iasmdsjk
7 Sep 23
Palatin Completes Enrollment in Phase 3 MELODY-1 Study of PL9643 For the Treatment of Patients with Dry Eye Disease
8:49am
8-K
0eg derrkmhx4l19u
10 Aug 23
Palatin Initiates Clinical Program for Bremelanotide Co-Formulated with a PDE5i for the Treatment of ED in Patients Non-Responsive to PDE5i Treatment
8:15am
8-K
ots9ps54 ligttkuu
8 Aug 23
Palatin Provides Update on VYLEESI® Collaborations
8:00am
8-K
14fi 3siet05oz3smx
7 Aug 23
Other Events
8:00am
8-K
5f9b2tgv6z8h4w5xy e0
4 Aug 23
Palatin to Participate in Canaccord Genuity’s 43rd Annual Growth Conference
8:00am
8-K
3npzet93
11 Jul 23
Palatin Announces Preliminary Fourth Quarter Fiscal 2023
8:25am
8-K
etzhzc9sclule3pqyci6
21 Jun 23
Submission of Matters to a Vote of Security Holders
9:01am
8-K
m193e
30 May 23
Palatin Presents Preclinical Diabetic Nephropathy Data at the International Podocyte Conference
9:30am
8-K
d7qjgw
16 May 23
Palatin Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update
8:15am
8-K
1abmgwezkrv43 aj3w
12 May 23
Other Events
8:44am
8-K
v0a8gpy 6tdk8
9 May 23
Palatin Invites Investors to Listen to Replay of the PL9643 Dry Eye Disease Key Opinion Leader Webinar
8:19am
8-K
bcjes79ckyducdbej2a
1 May 23
Other Events
4:45pm
8-K
133aza3t592ds
27 Apr 23
Palatin Presents Initial Dry Eye Disease Phase 3 Clinical Data at the Association of Research in Vision and Ophthalmology 2023 Annual Conference
8:30am
8-K
wa5gxr i4mlhep
25 Apr 23
Palatin Presents Data at the Association of Research in Vision
8:45am
8-K
zaal0jbh7
19 Apr 23
Palatin Announces Preliminary Third Quarter Fiscal 2023
1:40pm